Change in Cycle 1 to Cycle 2 Haematological Counts Predicts Toxicity in Older Patients with Breast Cancer Receiving Adjuvant Chemotherapy

By Hurria Arti   Brogan Kelly   Panageas Katherine S.   Jakubowski Ann   Zauderer Marjorie   Pearce Carol   Norton Larry   Howard Jane   Hudis Clifford  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 709-715

Adis International

Access to resources Recommend Favorite

Granulocyte-Colony Stimulating Factor Use and Medical Costs after Initial Adjuvant Chemotherapy in Older Patients with Early-Stage Breast Cancer

By Griffiths Robert I.   Barron Richard L.  

PharmacoEconomics, Vol. 30, Iss. 2, 2012-02 ,pp. : 103-118

Adis International

Access to resources Recommend Favorite

Heterogeneity of Breast Cancer among Patients and Implications for Patient Selection for Adjuvant Chemotherapy

By Andre Fabrice   Pusztai Lajos  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 1951-1958

Springer Publishing Company

Access to resources Recommend Favorite

Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years

By  

Cancer, Vol. 121, Iss. 22, 2015-11 ,pp. : 4062-4070

Blackwell Publishing

Access to resources Recommend Favorite

Adjuvant chemotherapy harms QOL in breast cancer

By  

Inpharma, Vol. 1, Iss. 1417, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite